GSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting a class of cell signaling molecules called interleukin-5, ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

The stock market can be a scary place for those who aren’t prepared. Our writer outlines three ways we might avoid getting ...

iTeos Therapeutics anticipates this year an interim readout from its Phase III GALAXIES Lung-301 trial of its anti-TIGIT antibody belrestotug in combination with GlaxoSmithKline's anti-PD-1 monoclonal ...

The latest generation of the venerable (try 45 years of consistent production) Geländewagen/G-Class/G-Wagen. Always a legend, a total overhaul back in 2018 saw it ...

MANILA, Philippines — Classes in public elementary and high schools resumed yesterday after almost two weeks of holiday break. While most college and university students are still enjoying their ...